Crossmark

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC)

Crossref DOI link: https://doi.org/10.1186/s12885-020-07127-2

Published Online: 2020-07-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bußmann, Lara

Laban, Simon

Wittekindt, Claus

Stromberger, Carmen

Tribius, Silke

Möckelmann, Nikolaus

Böttcher, Arne

Betz, Christian Stephan

Klussmann, Jens Peter

Budach, Volker

Muenscher, Adrian

Busch, Chia-Jung https://orcid.org/0000-0001-8254-8237
Funding

Funding for this research was provided by:

Deutsche Krebshilfe (1120027)
License Information

Text and Data Mining valid from 2020-07-29

Version of Record valid from 2020-07-29
More Information

Article History

Received: 20 May 2020

Accepted: 1 July 2020

First Online: 29 July 2020

Ethics approval and consent to participate

: This clinical trial has been approved by the ethics committee of the Ärztekammer in Hamburg (PVN5578). It is conducted in agreement with the ICH Harmonized Tripartite Guideline on Good Clinical Practice, valid since 17.01.1997, the Declaration of Helsinki (in its current version) and the respective national laws (in its current version).Informed consent, obtained from all patients, will be verbal and in written form.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below